Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CDMO Avid Bioservices, Inc.

休市中 08-23 16:00:00 EDT

10.58

-0.07

-0.66%

盘后10.58

+0.000.00%

19:18 EDT

最高10.95	最低10.48	成交量44.60万
今开10.76	昨收10.65	日振幅4.41%
总市值6.73亿	流通市值5.37亿	总股本6,358万
成交额474.04万	换手率0.88%	流通股本5,077万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":10.58,"timestamp":1724443200000,"preClose":10.65,"halted":0,"volume":445981,"hourTrading":{"tag":"盘后","latestPrice":10.58,"preClose":10.58,"latestTime":"19:18 EDT","volume":15562,"amount":164645.96,"timestamp":1724455133010},"delay":0,"floatShares":50774113,"shares":63581054,"eps":-2.23,"marketStatus":"休市中","marketStatusCode":7,"change":-0.07,"latestTime":"08-23 16:00:00 EDT","open":10.76,"high":10.95,"low":10.48,"amount":4740425.4820195,"amplitude":0.044131,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.23,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":10.65,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":10.58,"preClose":10.58,"latestTime":"19:18 EDT","volume":15562,"amount":164645.96,"timestamp":1724455133010},"volumeRatio":0.712516898975776,"impliedVol":0.6371,"impliedVolPercentile":0.3095},"requestUrl":"/m/hq/s/CDMO/tweets","defaultTab":"tweets","newsList":[{"id":"2461284463","title":"Avid Bioservices, Inc.盘中异动 急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461284463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461284463?lang=zh_cn&edition=full","pubTime":"2024-08-23 00:45","pubTimestamp":1724345134,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日00时45分，Avid Bioservices, Inc.股票出现异动，股价大幅下挫5.05%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823004534ab5f27fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823004534ab5f27fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","CDMOP","BK4139"],"gpt_icon":0},{"id":"2459471031","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459471031","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459471031?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:09","pubTimestamp":1723734597,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时09分，Lifecore Biomedical, Inc.股票出现异动，股价快速拉升5.65%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.05%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523095897198d78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523095897198d78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","CDMO","BK4212","BK4139","BK4121"],"gpt_icon":0},{"id":"2459541049","title":"普洛药业：上半年净利润6.25亿元 同比增长3.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459541049","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459541049?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:15","pubTimestamp":1723709708,"startTime":"0","endTime":"0","summary":"8月15日，普洛药业发布2024年半年度报告，报告期内公司营业收入为6,428,714,752.29元，同比增长7.96%。归属于上市公司股东的净利润为624,842,853.55元，同比增长3.96%。公司主营业务涵盖原料药中间体、创新药研发生产服务（CDMO）、制剂等研发、生产和销售以及进出口贸易业务。(财联社)","market":"other","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66bdc14a862ed477a0c918f6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2459152481","title":"Avid Bioservices, Inc.盘中异动 急速下跌5.02%报10.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459152481","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459152481?lang=zh_cn&edition=full","pubTime":"2024-08-15 03:00","pubTimestamp":1723662032,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日03时00分，Avid Bioservices, Inc.股票出现异动，股价大幅下挫5.02%。截至发稿，该股报10.22美元/股，成交量16.1164万股，换手率0.25%，振幅5.67%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081503003297198bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081503003297198bfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMOP","CDMO"],"gpt_icon":0},{"id":"2459904926","title":"战略转型CDMO成果显著 东曜药业-B(01875)上半年净利润3155.9万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2459904926","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459904926?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:02","pubTimestamp":1723557749,"startTime":"0","endTime":"0","summary":"东曜药业-B(01875)发布截至2024年6月30日止6个月业绩，该集团取得收益...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_46.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_46.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["CDMO","01875"],"gpt_icon":0},{"id":"2459976216","title":"逆境中的崛起：ADC药物市场热潮涌动 本土CDMO紧抓机遇寻增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2459976216","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459976216?lang=zh_cn&edition=full","pubTime":"2024-08-13 18:51","pubTimestamp":1723546288,"startTime":"0","endTime":"0","summary":"ADC市场消息不断，这一“网红”药物持续火热，ADC无疑将成为2024年的顶流赛道。8月13日，由第一三共和阿斯利康联合开发与商业化的优赫得?（Enhertu?，通用名：注射用德曲妥珠单抗）获中国国家药品监督管理局（NMPA）附条件批准，单药适用于治疗既往接受过两种或两种以上治疗方案的局部晚期或转移性HER2阳性成人胃或胃食管结合部腺癌患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202408133154989967.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202408133154989967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","BK4139","CDMO","BK4080","BK4231"],"gpt_icon":0},{"id":"2459915071","title":"尚渤投资：全球人口老龄化趋势下 投资制药业有两大低风险策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2459915071","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459915071?lang=zh_cn&edition=full","pubTime":"2024-08-13 11:31","pubTimestamp":1723519913,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，尚渤投资管理公司基金经理兼董事总经理Emily Leveille撰文称，全球人口老龄化带来的社会挑战和财富积累推动医疗保健领域不断创新。在审视全球制药业的投资机会时，Emily Leveille表示特别关注老龄化和慢性病副作用的潜在解决方案和治疗方法。随着未来数十年老龄化和财富增长的大趋势不断发展，制药业将在治疗慢性病和其他老年健康问题方面发挥重要作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2458986914","title":"Lifecore Biomedical, Inc.盘中异动 早盘大幅拉升6.08%报5.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458986914","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458986914?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:51","pubTimestamp":1723470673,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时51分，Lifecore Biomedical, Inc.股票出现异动，股价快速拉升6.08%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.13%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221511496825bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221511496825bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","BK4139","LFCR","CDMO"],"gpt_icon":0},{"id":"2457312491","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大涨5.60%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457312491","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457312491?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:21","pubTimestamp":1723126913,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时21分，Lifecore Biomedical, Inc.股票出现异动，股价大幅上涨5.60%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为4.13%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808222154aefdf1e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808222154aefdf1e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","LFCR","BK4121","BK4139","CDMO"],"gpt_icon":0},{"id":"2458449953","title":"施美药业IPO：毛利率与行业趋势背离 与第三大客户存诉讼纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2458449953","media":"核心价值发现者","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458449953?lang=zh_cn&edition=full","pubTime":"2024-08-08 14:48","pubTimestamp":1723099692,"startTime":"0","endTime":"0","summary":"毛利率远高于同业水平，产品业务单一，同时与第三大大客户存在诉讼纠纷，不仅如此，施美药业前高管还是公司第四大客户高管。深交所消息显示，正谋求创业板上市的江西施美药业股份有限公司（简称“施美药业”）近期更新了IPO招股说明书，保荐机构为国金证券。据招股书，此次公开发行股票数量不超过3500万股，拟募集资金为6....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/O4kegDYUaK2NlhmxoMt1I2a0whojxJYtF6IqeMsdJW5bsAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O4kegDYUaK2NlhmxoMt1I2a0whojxJYtF6IqeMsdJW5bsAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240808A051N800","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240808A051N800","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4139","01477","BK1515","CDMO","BK1161","BK1191","BK1574","09939"],"gpt_icon":0},{"id":"2457090567","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457090567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457090567?lang=zh_cn&edition=full","pubTime":"2024-08-06 02:01","pubTimestamp":1722880860,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日02时01分，Lifecore Biomedical, Inc.股票出现异动，股价快速下跌5.17%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为3.27%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806020100aefd50da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806020100aefd50da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4212","LFCR","CDMO","BK4121"],"gpt_icon":0},{"id":"2457370765","title":"太平洋8月5日发布研报称，给予奥翔药业（603229.SH）买入评级。评级理由主要包括：1）以特色原料药为基石，持续拓展CDMO、制剂业务；","url":"https://stock-news.laohu8.com/highlight/detail?id=2457370765","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457370765?lang=zh_cn&edition=full","pubTime":"2024-08-05 08:24","pubTimestamp":1722817455,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["601099","BK7095","CXO.AU","BK4139","CXO","CDMO","BK7504","BK0028","BK0276","BK0188","BK0077","BK0239","603229","BK0012","BK0183","BK0201"],"gpt_icon":0},{"id":"2456281738","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌6.47%报5.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456281738","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456281738?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:36","pubTimestamp":1722605778,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时36分，Lifecore Biomedical, Inc.股票出现异动，股价大幅下挫6.47%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.98%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213618941fd8fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213618941fd8fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4139","CDMO","BK4212","LFCR"],"gpt_icon":0},{"id":"2456431376","title":"Lifecore Biomedical, Inc.盘中异动 早盘急速下挫5.21%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456431376","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456431376?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:36","pubTimestamp":1722522990,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时36分，Lifecore Biomedical, Inc.股票出现异动，股价快速跳水5.21%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为1.43%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223630941fd06c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223630941fd06c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","BK4121","BK4212","CDMO","BK4139"],"gpt_icon":0},{"id":"2456110054","title":"浦银国际证券8月1日发布研报称，给予药明康德（603259.SH）买入评级。评级理由主要包括：1）2Q24收入大致符合市场预期，略高于我们预期；","url":"https://stock-news.laohu8.com/highlight/detail?id=2456110054","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456110054?lang=zh_cn&edition=full","pubTime":"2024-08-01 09:50","pubTimestamp":1722477041,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0320764599.SGD","161027","LU1046422090.SGD","CDMO","LU2125910500.SGD","LU2045819591.USD","BK1583","BK4139","LU0456842615.SGD","BK0216","LU1997245177.USD","LU2242644610.SGD","LU0052750758.USD","LU0708995583.HKD","BK1141","02359","603259","LU1997245094.SGD","BK1576"],"gpt_icon":0},{"id":"2455539181","title":"Avid Bioservices, Inc.盘中异动 大幅拉升5.18%报10.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455539181","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455539181?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:01","pubTimestamp":1722438071,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日23时01分，Avid Bioservices, Inc.股票出现波动，股价快速上涨5.18%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230111968224ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230111968224ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMOP","BK4139","CDMO"],"gpt_icon":0},{"id":"2455113738","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455113738","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455113738?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:10","pubTimestamp":1722435036,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日22时10分，Lifecore Biomedical, Inc.股票出现异动，股价急速下跌5.04%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.74%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731221037aefc7b88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731221037aefc7b88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4212","LFCR","CDMO","BK4121"],"gpt_icon":0},{"id":"2455787606","title":"研报掘金丨民生证券：药明康德在手订单快速提升，维持“推荐”评级民生证券研报指出，药明康德(603259.SH)在手订单快速提升，小分子CDMO龙头业绩环比改善。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455787606","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455787606?lang=zh_cn&edition=full","pubTime":"2024-07-30 15:48","pubTimestamp":1722325688,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2242644610.SGD","161726","LU1997245094.SGD","BK1576","399441","603259","LU0708995583.HKD","BK1583","02359","LU2125910500.SGD","LU0456842615.SGD","LU0052750758.USD","BK0216","BK7095","BK4139","BK1141","LU0320764599.SGD","161027","LU1997245177.USD","CXO","CDMO","CXO.AU","LU2045819591.USD","LU1046422090.SGD","BK7504"],"gpt_icon":0},{"id":"2455677233","title":"民生证券维持药明康德推荐评级，在手订单快速提升，小分子 CDMO 龙头业绩环比改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2455677233","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455677233?lang=zh_cn&edition=full","pubTime":"2024-07-30 14:37","pubTimestamp":1722321461,"startTime":"0","endTime":"0","summary":"民生证券07月30日发布研报称，维持药明康德（603259.SH，最新价：40.61元）推荐评级。评级理由主要包括：1）一体化需求持续增长，维持全年业绩指引不变；2）R端回暖拉动CDMO管线持续扩张，TIDES业务收入规模、在手订单和产能均快速提升；3）测试业务和生物学保持领先水平，WuXiATU新签订单有所承压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202407303143415941.html","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407303143415941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CDMO","02359"],"gpt_icon":0},{"id":"2455673677","title":"民生证券7月30日发布研报称，维持药明康德（603259.SH）推荐评级。评级理由主要包括：1）一体化需求持续增长，维持全年业绩指引不变；","url":"https://stock-news.laohu8.com/highlight/detail?id=2455673677","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455673677?lang=zh_cn&edition=full","pubTime":"2024-07-30 14:34","pubTimestamp":1722321243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1997245094.SGD","LU2045819591.USD","BK1583","CDMO","LU1046422090.SGD","LU0708995583.HKD","BK1576","LU0456842615.SGD","LU2242644610.SGD","161027","LU0052750758.USD","LU2125910500.SGD","603259","02359","LU1997245177.USD","BK0216","BK4139","BK1141","LU0320764599.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avidbio.com","stockEarnings":[{"period":"1week","weight":-0.0391},{"period":"1month","weight":0.1267},{"period":"3month","weight":0.2105},{"period":"6month","weight":0.3669},{"period":"1year","weight":-0.1019},{"period":"ytd","weight":0.6277}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avid Bioservices, Inc.最初于1981年6月在美国加州注册成立，并于1996年9月25日在美国特拉华州重新合并。该公司是一家专门的合同开发和制造组织（“CDMO”），提供从工艺开发到当前良好制造实践的全方位服务（“CGMP”）临床和商业制造，专注于从哺乳动物细胞培养中提取生物制药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.633333,"avgChangeRate":0.252871},{"month":2,"riseRate":0.566667,"avgChangeRate":0.058259},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.035156},{"month":4,"riseRate":0.4,"avgChangeRate":-0.032334},{"month":5,"riseRate":0.516129,"avgChangeRate":0.109027},{"month":6,"riseRate":0.419355,"avgChangeRate":0.007765},{"month":7,"riseRate":0.322581,"avgChangeRate":0.039463},{"month":8,"riseRate":0.354839,"avgChangeRate":0.002605},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.050651},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.037904},{"month":11,"riseRate":0.533333,"avgChangeRate":0.068059},{"month":12,"riseRate":0.4,"avgChangeRate":0.024422}],"exchange":"NASDAQ","name":"Avid Bioservices, Inc.","nameEN":"Avid Bioservices, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avid Bioservices, Inc.,CDMO,Avid Bioservices, Inc.股票,Avid Bioservices, Inc.股票老虎,Avid Bioservices, Inc.股票老虎国际,Avid Bioservices, Inc.行情,Avid Bioservices, Inc.股票行情,Avid Bioservices, Inc.股价,Avid Bioservices, Inc.股市,Avid Bioservices, Inc.股票价格,Avid Bioservices, Inc.股票交易,Avid Bioservices, Inc.股票购买,Avid Bioservices, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}